背景資料
This gene encodes a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation. This protein also plays a role in signal transduction pathways in the activation of T cells. Mutations in this gene cause CD59 deficiency, a disease resulting in hemolytic anemia and thrombosis, and which causes cerebral infarction. Multiple alternatively spliced transcript variants, which encode the same protein, have been identified for this gene.
別名
16.3A5,1F5,EJ16,EJ30,EL32,G344,HRF-20,HRF20,MAC-IP,MACIF,MEM43,MIC11,MIN1,MIN2,MIN3,MIRL,MSK21,p18-20,CD59 glycoprotein
關(guān)鍵字： Anti-CD59 Polyclonal Antibody;抗體
北京索萊寶科技有限公司是一家集研發(fā)、生產(chǎn)、銷售、服務(wù)于一體的高科技生物企業(yè)。技術(shù)推廣;技術(shù)轉(zhuǎn)讓；技術(shù)咨詢；技術(shù)服務(wù)；生物試劑技術(shù)開發(fā)；銷售生物試劑盒、實驗室專用化學試劑、實驗室專用設(shè)備、辦公用品、化工產(chǎn)品（不含危險化學品）、計算機軟件及輔助設(shè)備；貨物進出口、技術(shù)進出口、代理進出口；委托加工生產(chǎn)生物制品、生化制品、化工產(chǎn)品（不含危險化學品）；生產(chǎn)生物試劑盒；批發(fā)第一類醫(yī)療器械、第二類醫(yī)療器械；批發(fā)第三類醫(yī)療器械。